Cytochrome P450 3A4
Also known as: CYP3A3, CYP3A4
Function
A cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds. Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C-16 position. Plays a role in the metabolism of androgens, particularly in oxidative deactivation of testosterone. Metabolizes testosterone to less biologically active 2beta- and 6beta-hydroxytestosterones. Contributes to the formation of hydroxycholesterols (oxysterols), particularly A-ring hydroxylated cholesterol at the C-4beta position, and side chain hydroxylated cholesterol at the C-25 position, likely contributing to cholesterol degradation and bile acid biosynthesis. Catalyzes bisallylic hydroxylation of polyunsaturated fatty acids (PUFA). Catalyzes the epoxidation of double bonds of PUFA with a preference for the last double bond. Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling. Plays a role in the metabolism of retinoids. Displays high catalytic activity for oxidation of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA). Further metabolizes atRA toward 4-hydroxyretinoate and may play a role in hepatic atRA clearance. Responsible for oxidative metabolism of xenobiotics. Acts as a 2-exo-monooxygenase for plant lipid 1,8-cineole (eucalyptol). Metabolizes the majority of the administered drugs. Catalyzes sulfoxidation of the anthelmintics albendazole and fenbendazole. Hydroxylates antimalarial drug quinine. Acts as a 1,4-cineole 2-exo-monooxygenase. Also involved in vitamin D catabolism and calcium homeostasis. Catalyzes the inactivation of the active hormone calcitriol (1-alpha,25-dihydroxyvitamin D(3)).
Classification
- Family (Pfam)
- PF00067 p450
- InterPro
- Cyt_P450, Cyt_P450_CS, Cyt_P450_E_CYP3A, Cyt_P450_E_grp-II, Cyt_P450_sf, Cytochrome_P450_3A
- Functional cluster
- Cytochrome P450 & Heme Enzymes
Experimental structures · PDB · 119
- 1TQN X-ray 2.05A
- 1W0E X-ray 2.80A
- 1W0F X-ray 2.65A
- 1W0G X-ray 2.74A
- 2J0D X-ray 2.75A
- 2V0M X-ray 2.80A
- 3NXU X-ray 2.00A
- 3TJS X-ray 2.25A
- 3UA1 X-ray 2.15A
- 4D6Z X-ray 1.93A
- 4D75 X-ray 2.25A
- 4D78 X-ray 2.80A
- … and 107 more
A predicted model is available from AlphaFold.
Gene Ontology · 42
- GO:0005737 cytoplasm
- GO:0005789 endoplasmic reticulum membrane
- GO:0043231 intracellular membrane-bounded organelle
- GO:0102320 1,8-cineole 2-exo-monooxygenase activity
- GO:0062181 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity
- GO:0062188 anandamide 11,12 epoxidase activity
- GO:0062189 anandamide 14,15 epoxidase activity
- GO:0062187 anandamide 8,9 epoxidase activity
- GO:0034875 caffeine oxidase activity
- GO:0019899 enzyme binding
- GO:0101020 estrogen 16-alpha-hydroxylase activity
- GO:0101021 estrogen 2-hydroxylase activity
- GO:0020037 heme binding
- GO:0005506 iron ion binding
- GO:0004497 monooxygenase activity
- GO:0016491 oxidoreductase activity
- GO:0019825 oxygen binding
- GO:0050591 quinine 3-monooxygenase activity
- GO:0008401 retinoic acid 4-hydroxylase activity
- GO:0005496 steroid binding
- GO:0008395 steroid hydroxylase activity
- GO:0050649 testosterone 6-beta-hydroxylase activity
- GO:0070576 vitamin D 24-hydroxylase activity
- GO:0030343 vitamin D3 25-hydroxylase activity
- GO:0046222 aflatoxin metabolic process
- GO:0009822 alkaloid catabolic process
- GO:0008209 androgen metabolic process
- GO:0008203 cholesterol metabolic process
- GO:0008210 estrogen metabolic process
- GO:0002933 lipid hydroxylation
- GO:0006629 lipid metabolic process
- GO:0042759 long-chain fatty acid biosynthetic process
- GO:0016098 monoterpenoid metabolic process
- GO:0070989 oxidative demethylation
- GO:0042573 retinoic acid metabolic process
- GO:0042572 retinol metabolic process
- GO:0006706 steroid catabolic process
- GO:0008202 steroid metabolic process
- GO:0042369 vitamin D catabolic process
- GO:0042359 vitamin D metabolic process
- GO:0042178 xenobiotic catabolic process
- GO:0006805 xenobiotic metabolic process
Disease associations
- vitamin D-dependent rickets, type 3 MONDO:0033640
Drugs targeting this protein · 3
- RITONAVIR inhibitor
- COBICISTAT inhibitor
- TABIMORELIN inhibitor
Neighborhood · nearest proteins
Related proteins · sequence + function similarity
- Cytochrome P450 3A21 0.99
- Cytochrome P450 3A12 0.99
- Cytochrome P450 3A7 0.99
- Cytochrome P450 3A13 0.99
- Cytochrome P450 3A8 0.98
- Cytochrome P450 3A5 0.98
- Cytochrome P450 3A2 0.98
- Cytochrome P450 3A9 0.98
- Cytochrome P450 3A1 0.98
- Cytochrome P450 3A29 0.98
- Cytochrome P450 3A41 0.98
- Cytochrome P450 3A28 0.98
Co-cited proteins · studied together in the literature
- Cytochrome P450 3A5 7 shared papers
- Cytochrome P450 2C9 6 shared papers
- Cytochrome P450 1A2 8 shared papers
- Cytochrome P450 3A43 2 shared papers
- Aromatase 1 shared papers
- Flavin-containing monooxygenase 3 1 shared papers
- Cytochrome P450 3A7 4 shared papers
- 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial 1 shared papers
- Cytochrome P450 1A1 6 shared papers
- Cytochrome P450 2B6 3 shared papers
- Cytochrome P450 2D6 4 shared papers
- Cytochrome P450 2C8 4 shared papers
Literature · 45 cited papers
- CYP3A4 mutation causes vitamin D-dependent rickets type 3. J. Clin. Invest. · 2018
- Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance. Nat. Commun. · 2016
- An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J. Proteomics · 2014
- Oxidation of dihydrotestosterone by human cytochromes P450 19A1 and 3A4. J. Biol. Chem. · 2012
- Cholesterol 25-hydroxylation activity of CYP3A. J. Lipid Res. · 2011
- Evaluation of 6beta-hydroxycortisol, 6beta-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo. Clin. Pharmacol. Ther. · 2011
- Effects of a commonly occurring genetic polymorphism of human CYP3A4 (I118V) on the metabolism of anandamide. Drug Metab. Dispos. · 2010
- Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450. J. Lipid Res. · 2010
- Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab. Dispos. · 2009
- CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases. Arch. Biochem. Biophys. · 2009
- ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J. Neurochem. · 2008
- Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS ONE · 2008
- … and 33 more in the literature graph